F18-FDG-PET/CT standardised uptake value threshold in discriminating benign vs. malignant lesions. Doubts and certainties in the era of evidence-based medicine

Acta Oncologica

Volumn 51, Issue 1, 2012, Pages 122-144

  Bertagna, Francesco ^a   Giubbini, Raffaele ^a  

^a SPEDALI CIVILI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

BENIGN TUMOR; CANCER DIAGNOSIS; CANCER SIZE; CERVICAL LYMPH NODE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; EVIDENCE BASED MEDICINE; LETTER; LIVER ADENOMA; LUNG NODULE; MALIGNANT NEOPLASTIC DISEASE; MAXIMUM STANDARDISED UPTAKE VALUE; MEDIASTINUM LYMPH NODE; PRIORITY JOURNAL; THYROID ADENOMA;

EID: 83455262369     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.567997     Document Type: Letter

References (8)

1. Nguyen NC., Kaushik A., Wolverson MK., Osman MM. Is there a common SUV threshold in oncological FDG PET/CT., at least for some common indications? A retrospective study. Acta Oncol 2011 doi: 10.3109/0284186X.2010.550933.
2. Basu S., Zhuang H., Torigian DA., Rosenbaum J., Chen W., Alavi A. Functional imaging of inflammatory diseases using nuclear medicine techniques. Semin Nucl Med 2009;39:124-45.
3. Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: Present role and future possibilities. Semin Nucl Med 2009;39:36-51.
4. Kim BH., Na MA., Kim IJ., Kim SJ., Kim YK. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24:721-8.
5. Torigian DA., Alavi A. Positron emission tomography as a diagnostic tool in infection: Present role and future possibilities. Semin Nucl Med 2009;39:36-51
6. Kim BH, Na MA, Kim IJ, Kim SJ, Kim YK. Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation. Ann Nucl Med 2010;24:721-8.
7. Magini G, Farsad M, Frigerio M, Serra C, Colecchia A, [7] Jovine E, et al. C-11 acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma. Clin Nucl Med 2009;34: 659-65.
8. 'False-positive' uptake of FDG in a hepatic adenoma. Clin Nucl Med 1997;22:490-1.